Close
| |

Home Page

Company Database

Licensing Deals

Investors

Latest updates

27 February 2015
Updates within the latest 30 days:

News in the Life Sciences Industry

Results 1 - 20 out of 500 displayed.
1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25 - Next
Reset 

New Report Details How to Expand a Pharmaceutical Product Portfolio without Cannibalizing an Established Brand

CHAPEL HILL, N.C., Feb. 27, 2015 /PRNewswire/ -- Pharmaceutical and biotech marketers are often faced with the challenge of managing multiple products for the same indication. This can be a complex balancing act -- especially for those that want to prevent one of their brands from gaining market... Read more ››

By: PR Newswire Association LLC. - 28 Feb 2015

Improving the Management of MSL Teams to Create Value across a Diverse Set of Customers

CHAPEL HILL, N.C., Feb. 27, 2015 /PRNewswire/ -- The role of the Medical Science Liaison has evolved over the past decade but one thing hasn't changed: face-to-face meetings are seen as the best way for MSLs to build relationships with Key Opinion Leaders.

Read more ››
By: PR Newswire Association LLC. - 28 Feb 2015

WuXi Congratulates TaiMed Biologics on Receiving Breakthrough Therapy Designation from U.S. FDA

SHANGHAI, Feb. 27, 2015 /PRNewswire/ -- WuXi PharmaTech (Cayman) Inc. (NYSE: WX), a leading open-access R&D capability and technology platform company serving the pharmaceutical, biotechnology, and medical device industries with operations in China and the United States, congratulates our... Read more ››

By: PR Newswire Association LLC. - 27 Feb 2015
Related companies:  WuXi AppTec | WuXi AppTec, Inc.

In Pre-Clinical Studies Ibrutinib Enhances Anti-tumor Activity When Combined With An Anti-PD-L1 Antibody

SUNNYVALE, Calif., Feb. 27, 2015 /PRNewswire/ -- Pharmacyclics, Inc. (NASDAQ: PCYC) today highlighted findings from a pre-clinical study published in the Proceedings of the National Academy of Sciences (www.pnas.org/cgi/doi/10.1073/pnas.1500712112)... Read more ››

By: PR Newswire Association LLC. - 27 Feb 2015
Related companies:  Pharmacyclics, Inc.

Pharmacyclics Provides Clinical Update on BTK Inhibitor for Autoimmune Diseases

SUNNYVALE, Calif., Feb. 27, 2015 /PRNewswire/ -- Pharmacyclics, Inc. (NASDAQ: PCYC) today announced that longer-term toxicology studies for its newly developed Bruton's tyrosine kinase (BTK) inhibitor for rheumatoid arthritis, or RA, have been completed. The results of these preclinical evaluations... Read more ››

By: PR Newswire Association LLC. - 27 Feb 2015
Related companies:  Pharmacyclics, Inc.

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Vitae Pharmaceuticals, Inc. - VTAE

NEW YORK, Feb. 27, 2015 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Vitae Pharmaceuticals, Inc. ("Vitae" or the "Company") (NASDAQ: VTAE). Such investors are advised to contact Robert S. Willoughby at Read more ››

By: PR Newswire Association LLC. - 27 Feb 2015
Related companies:  Vitae Pharmaceuticals

Intrexon to Acquire Okanagan Specialty Fruits

GERMANTOWN, Md. and SUMMERLAND, British Columbia, Feb. 27, 2015 /PRNewswire/ -- Intrexon Corporation (NYSE: XON), a leader in synthetic biology, today announced it has entered into an agreement to acquire Read more ››

By: PR Newswire Association LLC. - 27 Feb 2015
Related companies:  Intrexon Corporation

Survey Published in AMCP's JMCP Finds Pharmacists Are Most Confident Substituting Interchangeable Biosimilars for Brand Biologics When Products Share Nonproprietary Name

ALEXANDRIA, Va., Feb. 27, 2015 /PRNewswire-USNewswire/ -- Roughly three-quarters of pharmacists said they would feel confident or very confident substituting an interchangeable biosimilar for its branded biologic counterpart if the two products share the same nonproprietary name, according to... Read more ››

By: PR Newswire Association LLC. - 27 Feb 2015

Mylan Completes Acquisition Of Abbott's Non-U.S. Developed Markets Specialty And Branded Generics Business

POTTERS BAR, England and PITTSBURGH, Feb. 27, 2015 /PRNewswire/ -- Mylan N.V. and Mylan Inc. (Nasdaq: MYL) today announced the successful completion of the acquisition of Abbott Laboratories' (NYSE: ABT) non-U.S. developed markets specialty and branded generics business.

Read more ››
By: PR Newswire Association LLC. - 27 Feb 2015
Related companies:  Abbott Laboratories

Lightlake Therapeutics Inc., Licensor Of A Treatment To Reverse Opioid Overdoses, To Webcast Live, At VirtualInvestorConferences.com March 5th

Lightlake invites individual and institutional investors to attend interactive real-time presentation on Lightlake's progress with its opioid overdose reversal treatment and achievements in other areas.

Read more ››
By: PR Newswire Association LLC. - 27 Feb 2015

Translational Regenerative Medicine: Market Prospects 2015-2025

LONDON, February 27, 2015 /PRNewswire/ --

Read more ››
By: PR Newswire Association LLC. - 27 Feb 2015

FDAnews New Workshop -- Software and Cybersecurity Risk Management for Medical Devices: Understanding the FDA's Position and Best Practices for Compliance, April 14-15, 2015

FALLS CHURCH, Va., Feb. 27, 2015 /PRNewswire-iReach/ -- Software and Cybersecurity Risk Management for Medical Devices:
Understanding the FDA's Position and Best Practices for Compliance
**Presented by FDAnews and GessNet**
April 14-15, 2015 - Bethesda, MD
Read more ››

By: PR Newswire Association LLC. - 27 Feb 2015

RMSR Medical Sales Training on Increase for Aspiring Medical Device Sales Candidates

KANSAS CITY, Mo., Feb. 27, 2015 /PRNewswire-iReach/ -- The National Association of Medical Sales Representatives' (NAMSR) recent survey results show that RMSR entry level training for medical device sales is rapidly increasing for aspiring reps. RMSR Training is now looked for as a preferred... Read more ››

By: PR Newswire Association LLC. - 27 Feb 2015

Bayer Honors Patients with Rare Diseases on 7th Annual Rare Disease Day

Read more ››
By: PR Newswire Association LLC. - 27 Feb 2015

Isis Reports Financial Results and Highlights for 2014

CARLSBAD, Calif., Feb. 27, 2015 /PRNewswire/ -- Isis Pharmaceuticals, Inc. (Nasdaq: ISIS) today announced it significantly outperformed both its pro forma net operating loss (NOL) guidance and its cash guidance ending the year in a strong financial position. Isis' significantly improved financial... Read more ››

By: PR Newswire Association LLC. - 27 Feb 2015
Related companies:  Isis Pharmaceuticals, Inc.

Curb Overuse Of Antibiotics To Reduce Drug-Resistant Superbug

RIDGEWOOD, N.J., Feb. 27, 2015 /PRNewswire-USNewswire/ -- An aggressive campaign to reduce the unnecessary use of antibiotics has helped cut the rate of infection with a dangerous drug-resistant bacteria at The Valley Hospital by nearly 40 percent.

Read more ››
By: PR Newswire Association LLC. - 27 Feb 2015

Salix Pharmaceuticals, Ltd. Stockholders Encouraged to Contact Securities Law Firm about Takeover

NEW YORK, Feb. 27, 2015 /PRNewswire/ -- Securities lawyers at Dunnam & Dunnam are investigating the board of Salix Pharmaceuticals, Ltd. (NASDAQ: SLXP) in connection with a buyout for only $158.00... Read more ››

By: PR Newswire Association LLC. - 27 Feb 2015
Related companies:  Salix Pharmaceuticals, Inc.

FAA Announces New Sleep Apnea Guidance for Aviation Medical Examiners, Surgical Sleep Solutions Offers Innovative Treatment Model

MISSOULA, Mont., Feb. 27, 2015 /PRNewswire/ -- The Federal Aviation Administration (FAA) has announced that it will issue new guidance for aviation medical examiners (AMEs) regarding the screening and treatment of obstructive sleep apnea (OSA) in commercial pilots. The new guidance, which hopes... Read more ››

By: PR Newswire Association LLC. - 27 Feb 2015

The Fastest Growing Patient Healthcare App in America Closes Next Round Of Funding

GREENVILLE, S.C., Feb. 27, 2015 /PRNewswire/ -- ChartSpan Medical Technologies announced it has successfully raised a capital round of $1.7 million dollars. Since becoming the most downloaded iPhone and iPad medical app in the U.S. in December, ChartSpan continues to disrupt healthcare with innovative... Read more ››

By: PR Newswire Association LLC. - 27 Feb 2015

Bidding Fix Takes Major Step Forward After Bipartisan Vote of House Ways and Means Committee

WASHINGTON, Feb. 27, 2015 /PRNewswire-USNewswire/ -- Following a bipartisan vote in the House Ways and Means Committee that moved H.R. 284, the Medicare DMEPOS Competitive Bidding Improvement Act of 2015 forward, the American Association for Homecare (AAHomecare) released a statement... Read more ››

By: PR Newswire Association LLC. - 27 Feb 2015
1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25 - Next